Search Results for

Clear All Filters

September 29, 2021 | The American Prospect

Fatou Ndiaye Timi Iwayemi

Op-Ed

CoronavirusForeign PolicyPharmaTrade Policy

How to Vaccinate the World

When United States Trade Representative Katherine Tai announced this past May that the U.S. would support the TRIPS waiver on COVID-19 vaccines at the World Trade Organization (WTO), we at the Revolving Door Project celebrated the administration’s decision as “a transformative, hopeful event.” The waiver proposal calls on the WTO’s Trade-Related Aspects of Intellectual Property Rights (TRIPS) Council to suspend intellectual-property protections on COVID-19 therapeutics, diagnostics, and vaccines to ensure materials necessary for combating the pandemic are “available promptly, in sufficient quantities and at affordable price to meet global demand.”

September 24, 2021

Jeff Hauser

Press Release

CoronavirusIntellectual Property

Biden Administration’s Inaction on Vaccine Equity is Cowardly and Shameful

“Over four months after announcing its support for the COVID-19 TRIPS Waiver, the Biden administration’s once promising step towards achieving vaccine equity is proving to be little more than an empty promise. Officials across the administration are cowering in the face of Big Pharma’s insatiable appetite for profit rather than pursuing one of many paths to rapidly ensure equitable access to vaccines worldwide.”

April 16, 2021

Fatou Ndiaye Zena Wolf

Blog Post

CoronavirusExecutive BranchIntellectual PropertyRevolving Door

The Brother Of A Pharma Lobbyist Advises Biden As He Weighs Vaccine IP Waiver

Despite pushback from progressives, Ricchetti has continued to hold a powerful advisory position in the Biden White House. His background in corporate lobbying and strong ties to the pharmaceutical industry are deeply troubling signs as the Biden Administration faces enormously consequential decisions about how to end the COVID-19 pandemic.

April 08, 2021

Sion Bell

Blog Post

CoronavirusDepartment of CommerceIntellectual Property

Secretary Raimondo Must Act Quickly to Support the TRIPS Waiver

As the Biden administration continues to tackle the Covid-19 pandemic, Commerce Secretary Gina Raimondo holds one of the most critical but under-appreciated roles for ensuring vaccine distribution. Indeed, the Commerce Secretary is a key player determining more generally whether America and the planet prioritize Big Pharma’s wealth or public health.

March 18, 2021

Press Release

CoronavirusExecutive BranchForeign Policy

Congress Must Examine Biden Admin Possibly Trading Vaccines For Anti-Migration Enforcement

The Revolving Door Project is outraged by yesterday’s news that the Biden administration has been pressuring the Mexican government into turning away migrants at the Mexico-Guatemala border. While this Trump style initiative would be appalling on its own, we are additionally concerned about the possibility that President Biden may have bartered millions of doses of the AstraZeneca vaccine to achieve his anti-migration goals.

March 15, 2021 | Independent Media Institute

Elias Alsbergas

Op-Ed

ClimateCoronavirusEthics in GovernmentRevolving Door

When Public Officials Get Rented Out By Corporate Power, The People Lose

From Vivek Murthy’s lucrative consulting work with Netflix and Carnival Cruise Lines to Brian Deese’s “greenwashing” of fossil fuel investments at BlackRock, the revolving door between corporate industry and government continues to undermine public trust in the Biden Administration, writes our Elias Alsbergas.